SciELO - Scientific Electronic Library Online

 
vol.33 número4Frecuencia del HLA-B*27:: algunas consideraciones sobre su uso como herramienta diagnósticaHaplotipo HLA infrecuente en un estudio familiar de histocompatibilidad para trasplante de células progenitoras hematopoyéticas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Hematología, Inmunología y Hemoterapia

versión On-line ISSN 1561-2996

Resumen

DUQUE ESTRADA, Lidia; BETANCOURT REYES, Gilberto Lázaro; BETANCOURT BETANCOURT, Gilberto de Jesús  y  JUNCO BONET, Miguel Damián. Chronic lymphocytic leukemia with eye infiltration. Rev Cubana Hematol Inmunol Hemoter [online]. 2017, vol.33, n.4, pp. 85-91. ISSN 1561-2996.

The incidence of chronic lymphocytic leukemia (CLL) increases progressively with age, approximately 75% of cases present 60 years or more. This type of leukemia is more frequent in men and its cause is unknown, there are cases that are of hereditary origin. A clinical case of a patient with the diagnosis of Chronic Lymphocytic Leukemia with ocular infiltration is presented. A 76-year-old white male patient with a health history of having been diagnosed with a Chronic Lymphocytic Leukemia for 5 years who is treated with Leukeran (Chlorambucil) ( 2mg) 2 tab at lunch and 3 at night; and prednisone (5mg) 1 tab every 8 hours. About 3 days ago begins with asthenia, anorexia, dizziness, pain and swelling of the upper right eyelid. Physical examination, upper eyelid biopsy and blood smears reveal the presence of a hematological relapse with ocular infiltration.

Palabras clave : chronic lymphocytic leukemia; ocular infiltration; clinical manifestations; biopsy; case report.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License